DanCann Pharma A/S: CEO Jeppe Krog Rasmussen buys more shares in DanCann Pharma A/S

Report this content

COPENHAGEN, Denmark, 3 March 2021 - DanCann Pharma A/S (SS: DANCAN) (“DanCann Pharma” or the “Company”) hereby announce that Jeppe Krog Rasmussen, Founder, Board Member and CEO at DanCann Pharma A/S has privately through his holding company (JKR INVESTMENT GROUP ApS) bought 40,000 shares in DanCann Pharma A/S at an average price of DKK 3.14 per share.

The shares were purchased in the ongoing trading on Spotlight Stock Market on Monday 1 March 2021.

Following this transaction, Jeppe Krog Rasmussen now directly through his holding company (JKR INVESTMENT GROUP ApS) controls 5,380,000 shares, corresponding to approx. 25.95 percent (25.76 percent before) in total at DanCann Pharma.

About DanCann Pharma

DanCann Pharma A/S (SS: DANCAN) was founded in 2018 and is a Danish biopharmaceutical company powered by cannabinoids. DanCann Pharma is a vertically integrated, licensed production and distribution company based in Denmark. The company focuses on discovering, developing, manufacturing, and commercializing new therapeutic cannabinoids in a wide range of disease areas.

For further information, please contact:

Jeppe Krog Rasmussen, CEO
Website: www.dancann.com


Documents & Links